When Brain Becomes Blood

For this article, Eugene Russo interviewed Christopher R.R. Bjornson, a graduate student in the department of biochemistry at the University of Washington in Seattle. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. C.R.R. Bjornson, R.L. Rietze, B.A. Reynolds, M.C. Magli, A.L. Vescovi, "Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo,"Science, 283

Written byEugene Russo
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The now disbanded NeuroSpheres laboratory team showed that in mice, neural stem cells (NSCs) could become hematopoietic cells in vivo. According to lead author Christopher R. R. Bjornson, now a biochemistry graduate student at the University of Washington, the NeuroSpheres researchers noted a few instances in which certain cells would express traits of other cell lineages.4 "From that we started to really question ... whether or not stem cells were only confined to a certain subset of fates," he explains.

To test this concept, he and his colleagues first irradiated mice to eliminate most of the animals' endogenous hematopoietic precursors. A key step, says Bjornson, was using a sub-lethal dose of radiation rather than lethal doses, which often are used for bone marrow (BM) transplants. They correctly reasoned that the NSCs would take longer than BM cells to become hematopoietic and they did not want the mice to degenerate too ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies